Fulgent Genetics Affirms FY2025 Adj EPS Guidance of $(0.65) vs $(0.66) Est; Affirms FY2025 Sales Guidance of $310.00M vs $310.44M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Fulgent Genetics (NASDAQ:FLGT) affirms FY2025 Adj EPS guidance from $(0.65) to $(0.65) vs $(0.66) analyst estimate. Affirms FY2025 sales outlook from $310.00 million to $310.00 million vs $310.44 million estimate.
Fulgent Genetics (NASDAQ:FLGT) affirms FY2025 Adj EPS guidance from $(0.65) to $(0.65) vs $(0.66) analyst estimate. Affirms FY2025 sales outlook from $310.00 million to $310.00 million vs $310.44 million estimate.